Latest 10-K annual reports

KAT Exploration, Inc.'s 10-K filing reveals a net loss, limited operations focused on seeking a business combination, and a recent joint venture in gold mining.

Medicus Pharma Ltd. files an amendment to its annual report on Form 10-K to include information required by Part III, covering directors, executive officers, corporate governance, and executive compensation.

Sotherly Hotels Inc. and Sotherly Hotels LP file an amendment to their Annual Report on Form 10-K for the fiscal year ended December 31, 2024, to include information required by Part III regarding directors, executive officers, and corporate governance.

IIOT-OXYS, Inc.'s 10-K filing reveals a decrease in revenue, a net loss, and substantial doubt about the company's ability to continue as a going concern due to limited funding and operational headwinds.

The Cannabist Company Holdings Inc. amends its annual report on Form 10-K to correct a typographical error in the auditor's report and include a performance graph.

XBP Europe Holdings files an amendment to its 2024 Annual Report to include previously omitted information regarding directors, executive compensation, ownership, related transactions, accountant fees, and to introduce an executive severance plan.

Newmark Group amends its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.

Synlogic files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and accounting fees.

Nutex Health files an amendment to its annual report to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related person transactions, and principal accountant fees.

Old Point Financial Corporation files an amendment to its 2024 annual report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance, as well as an updated exhibit index, ahead of its merger with TowneBank.

Powerdyne International, Inc. reports a decrease in revenue and an increased net loss for the year ended December 31, 2024, compared to the previous year, while addressing going concern uncertainties.

22nd Century Group files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Pulse Biosciences files an amendment to its 2024 Annual Report on Form 10-K to include information previously omitted regarding directors, executive officers, compensation, and corporate governance.

WidePoint Corporation files an amendment to its annual report on Form 10-K to include previously omitted information from Part III, Items 10-14.

Vocodia Holdings Corp's 2024 annual report reveals a significant revenue drop due to product suspension and ongoing legal battles, raising concerns about the company's financial stability.

Borealis Foods Inc. files Amendment No. 1 to its Form 10-K/A to include Part III information regarding directors, executive officers, compensation, security ownership, related party transactions, and principal accountant fees, along with updated certifications.

Shattuck Labs files an amendment to its 2024 Annual Report on Form 10-K/A to include information required by Items 10 through 14 of Part III, covering directors, executive compensation, security ownership, related transactions, and principal accountant fees.

Dun & Bradstreet filed an amendment to its 2024 annual report, updating information on directors, officers, and executive compensation.

Data Storage Corporation files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III regarding directors, executive officers, and corporate governance.

Lantern Pharma files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance.

INVO Fertility, formerly NAYA Biosciences, will refocus on its fertility business and divest its NAYA Therapeutics subsidiary after failing to gain shareholder support for key transaction elements.

Conifer Holdings files an amendment to its 2024 annual report, providing updated information on directors, executive compensation, related party transactions, and corporate governance.

Accelerate Diagnostics files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.

Global Star Acquisition Inc. reports its 10-K filing, highlighting challenges with Nasdaq listing compliance and ongoing efforts to complete its merger with K Enter Holdings Inc.

Creative Media & Community Trust Corporation files an amendment to its 2024 annual report on Form 10-K to provide information previously omitted regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and accountant fees.

Global Interactive Technologies, Inc. (GITS) reports its 2024 10-K filing, highlighting a year of restructuring, leadership changes, and strategic shifts towards its FANING platform, while addressing going concern uncertainties and outlining future growth strategies.

IGM Biosciences files an amendment to its annual report to provide additional details on its board of directors, executive compensation, and corporate governance practices.

RingCentral files an amendment to its 2024 annual report to include information required in Part III, related to directors, executive officers, and executive compensation.

Talphera, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include updated information on directors, executive officers, corporate governance, executive compensation, and related matters.

bioAffinity Technologies files an amendment to its annual report on Form 10-K to include information required by Part III regarding directors, executive officers, and corporate governance.